CUTANEOUS LUPUS
Clinical trials for CUTANEOUS LUPUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug, SAR448501/DR-0201, in 62 adults with lupus or rheumatoid arthritis. The goal is to find the safest and most effective dose by checking side effects and how the drug works in the body. Participants will be followed for about 13 months, and …
Matched conditions: CUTANEOUS LUPUS
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
New registry aims to unlock secrets of autoimmune disease in pregnancy
Knowledge-focused Recruiting nowThis study is creating a registry of 1,000 pregnant women with autoimmune diseases like lupus and rheumatoid arthritis. Researchers will track their health and pregnancy outcomes to identify risk factors and ways to improve care for both mothers and babies. The study does not tes…
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 17, 2026 03:14 UTC
-
Lupus patients needed for Long-Term study
Knowledge-focused Recruiting nowThis study is creating a registry of 1,000 people with lupus (systemic lupus erythematosus or cutaneous lupus) who are seen at Duke Rheumatology clinics. Researchers will collect medical information and blood samples over time to learn how lupus changes and affects patients. The …
Matched conditions: CUTANEOUS LUPUS
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC